JP2019519484A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019519484A5 JP2019519484A5 JP2018557818A JP2018557818A JP2019519484A5 JP 2019519484 A5 JP2019519484 A5 JP 2019519484A5 JP 2018557818 A JP2018557818 A JP 2018557818A JP 2018557818 A JP2018557818 A JP 2018557818A JP 2019519484 A5 JP2019519484 A5 JP 2019519484A5
- Authority
- JP
- Japan
- Prior art keywords
- acetamide
- pyrazol
- sulfamoylphenyl
- chlorophenyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 methylenedioxy group Chemical group 0.000 claims 229
- 229910052739 hydrogen Inorganic materials 0.000 claims 45
- 239000001257 hydrogen Substances 0.000 claims 45
- 229910052736 halogen Inorganic materials 0.000 claims 39
- 150000002367 halogens Chemical group 0.000 claims 36
- 150000002431 hydrogen Chemical group 0.000 claims 32
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims 27
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 27
- 150000001875 compounds Chemical class 0.000 claims 26
- 125000004093 cyano group Chemical group *C#N 0.000 claims 25
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 25
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 21
- 208000002193 Pain Diseases 0.000 claims 21
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 20
- 230000036407 pain Effects 0.000 claims 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 15
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 11
- 125000001072 heteroaryl group Chemical group 0.000 claims 11
- 201000010099 disease Diseases 0.000 claims 10
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 claims 9
- 125000001153 fluoro group Chemical group F* 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 8
- 201000009273 Endometriosis Diseases 0.000 claims 7
- 150000001204 N-oxides Chemical class 0.000 claims 7
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 7
- 208000035475 disorder Diseases 0.000 claims 7
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 7
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 6
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 claims 6
- 239000012453 solvate Substances 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 3
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 3
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 claims 3
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 claims 3
- 208000005171 Dysmenorrhea Diseases 0.000 claims 3
- 206010013935 Dysmenorrhoea Diseases 0.000 claims 3
- 208000004483 Dyspareunia Diseases 0.000 claims 3
- 206010020751 Hypersensitivity Diseases 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 208000026935 allergic disease Diseases 0.000 claims 3
- 230000001684 chronic effect Effects 0.000 claims 3
- 230000002496 gastric effect Effects 0.000 claims 3
- 125000001188 haloalkyl group Chemical group 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- NKFLEFWUYAUDJV-UHFFFAOYSA-N pyridine-3-sulfonamide Chemical compound NS(=O)(=O)C1=CC=CN=C1 NKFLEFWUYAUDJV-UHFFFAOYSA-N 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- CBVBUDSEEGXIRC-HOTGVXAUSA-N 2-(2-chlorophenyl)-N-[4-[4-[(2S,5S)-2,5-dimethylpyrrolidin-1-yl]pyrazol-1-yl]-3-sulfamoylphenyl]acetamide Chemical compound C[C@H]1CC[C@H](C)N1c1cnn(c1)-c1ccc(NC(=O)Cc2ccccc2Cl)cc1S(N)(=O)=O CBVBUDSEEGXIRC-HOTGVXAUSA-N 0.000 claims 2
- NEURYOYRKPFLKH-UHFFFAOYSA-N 2-chloro-1-isocyanato-4-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC=C(N=C=O)C(Cl)=C1 NEURYOYRKPFLKH-UHFFFAOYSA-N 0.000 claims 2
- 206010016654 Fibrosis Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 206010065390 Inflammatory pain Diseases 0.000 claims 2
- 208000008930 Low Back Pain Diseases 0.000 claims 2
- MKJMGCGGPAJFCB-UHFFFAOYSA-N N-[4-bromo-3-(dimethylaminomethylideneamino)sulfonylphenyl]-2-(2-chlorophenyl)acetamide Chemical compound BrC1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(N=CN(C)C)(=O)=O MKJMGCGGPAJFCB-UHFFFAOYSA-N 0.000 claims 2
- 208000000450 Pelvic Pain Diseases 0.000 claims 2
- 206010003246 arthritis Diseases 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 230000013872 defecation Effects 0.000 claims 2
- 206010013990 dysuria Diseases 0.000 claims 2
- 230000004761 fibrosis Effects 0.000 claims 2
- 230000003176 fibrotic effect Effects 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 230000009610 hypersensitivity Effects 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 208000004296 neuralgia Diseases 0.000 claims 2
- WRFOJGXVZQHQRF-UHFFFAOYSA-N 1-[2-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-nitrophenyl]pyrazole-4-carboxylic acid Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=CC(=C2)C(=O)O)C=CC(=C1)OC WRFOJGXVZQHQRF-UHFFFAOYSA-N 0.000 claims 1
- YXJYVKZMIASXAG-UHFFFAOYSA-N 1-[4-[[2-(2-chlorophenyl)acetyl]amino]-2-sulfamoylphenyl]-N-cyclopropyl-N-methylpyrazole-4-carboxamide Chemical compound CN(C1CC1)C(=O)c1cnn(c1)-c1ccc(NC(=O)Cc2ccccc2Cl)cc1S(N)(=O)=O YXJYVKZMIASXAG-UHFFFAOYSA-N 0.000 claims 1
- UUBYQHPZHKFMTG-UHFFFAOYSA-N 2-(2-bromophenyl)-N-[3-sulfamoyl-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl]acetamide 2-(2,4-difluorophenyl)-N-[3-sulfamoyl-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl]acetamide Chemical compound FC1=C(C=CC(=C1)F)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O.BrC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O UUBYQHPZHKFMTG-UHFFFAOYSA-N 0.000 claims 1
- WFWOKUIHMRBMMC-UHFFFAOYSA-N 2-(2-chloro-3,6-difluorophenyl)-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C(=CC=C1F)F)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N)(=O)=O WFWOKUIHMRBMMC-UHFFFAOYSA-N 0.000 claims 1
- HECFUHGLZHWEBY-UHFFFAOYSA-N 2-(2-chloro-4,5-difluorophenyl)-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C=C(C(=C1)F)F)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N)(=O)=O HECFUHGLZHWEBY-UHFFFAOYSA-N 0.000 claims 1
- DWWXZBCXDPIIEW-UHFFFAOYSA-N 2-(2-chloro-4-fluorophenyl)-N-[3-sulfamoyl-4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C=CC(=C1)F)CC(=O)NC1=CC(=C(C=C1)N1N=C(N=C1)C(F)(F)F)S(N)(=O)=O DWWXZBCXDPIIEW-UHFFFAOYSA-N 0.000 claims 1
- AXJHRVLFGPAXBK-UHFFFAOYSA-N 2-(2-chloro-5-fluorophenyl)-N-[3-sulfamoyl-4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2cc(F)ccc2Cl)ccc1-n1cnc(n1)C(F)(F)F AXJHRVLFGPAXBK-UHFFFAOYSA-N 0.000 claims 1
- OTLVSNJUJOOHPB-UHFFFAOYSA-N 2-(2-chloro-5-fluorophenyl)-N-[4-[1-(difluoromethyl)pyrazol-4-yl]-3-sulfamoylphenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2cc(F)ccc2Cl)ccc1-c1cnn(c1)C(F)F OTLVSNJUJOOHPB-UHFFFAOYSA-N 0.000 claims 1
- RYHZLLODHLOTKS-UHFFFAOYSA-N 2-(2-chloro-5-methylphenyl)-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C=C(C=C1)C)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N)(=O)=O RYHZLLODHLOTKS-UHFFFAOYSA-N 0.000 claims 1
- GXTOAJYKJQVLRS-UHFFFAOYSA-N 2-(2-chloro-6-fluoro-3-methylphenyl)-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C(=CC=C1C)F)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N)(=O)=O GXTOAJYKJQVLRS-UHFFFAOYSA-N 0.000 claims 1
- VUBLKOPPIWFMFK-UHFFFAOYSA-N 2-(2-chloro-6-fluorophenyl)-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide 2-(2-methoxyphenyl)-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C(=CC=C1)F)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N)(=O)=O.COC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N)(=O)=O VUBLKOPPIWFMFK-UHFFFAOYSA-N 0.000 claims 1
- LIMPZMGFKMXMJK-UHFFFAOYSA-N 2-(2-chloro-6-fluorophenyl)-N-[4-(6-chloropyridin-3-yl)-3-sulfamoylphenyl]acetamide N-[4-(6-chloropyridin-3-yl)-3-sulfamoylphenyl]-2-[4-(trifluoromethyl)phenyl]acetamide Chemical compound ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)C(F)(F)F)=O)S(N)(=O)=O.ClC1=C(C(=CC=C1)F)CC(=O)NC1=CC(=C(C=C1)C=1C=NC(=CC1)Cl)S(N)(=O)=O LIMPZMGFKMXMJK-UHFFFAOYSA-N 0.000 claims 1
- IRLXVYHKRZXIME-UHFFFAOYSA-N 2-(2-chloro-6-methoxyphenyl)-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C(=CC=C1)OC)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N)(=O)=O IRLXVYHKRZXIME-UHFFFAOYSA-N 0.000 claims 1
- RRBGMAAPGQFCFU-UHFFFAOYSA-N 2-(2-chlorophenyl)-2,2-difluoro-N-[3-sulfamoyl-4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)C(F)(F)c2ccccc2Cl)ccc1-n1cnc(n1)C(F)(F)F RRBGMAAPGQFCFU-UHFFFAOYSA-N 0.000 claims 1
- VAHUDOHTZQAQBR-UHFFFAOYSA-N 2-(2-chlorophenyl)-2-hydroxy-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)C(O)c2ccccc2Cl)ccc1-n1cc(cn1)C(F)(F)F VAHUDOHTZQAQBR-UHFFFAOYSA-N 0.000 claims 1
- JNONWZWBKPDTKL-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-(dimethylaminomethylideneamino)sulfonyl-4-(1-methylpyrrol-3-yl)phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN(C=C1)C)S(N=CN(C)C)(=O)=O JNONWZWBKPDTKL-UHFFFAOYSA-N 0.000 claims 1
- PALDDDCDUCGIIK-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-(dimethylaminomethylideneamino)sulfonyl-4-(1H-pyrazol-4-yl)phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NNC=1)S(N=CN(C)C)(=O)=O PALDDDCDUCGIIK-UHFFFAOYSA-N 0.000 claims 1
- KAPVKSYSBOIXJZ-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-(dimethylaminomethylideneamino)sulfonyl-4-(4-fluoropyrazol-1-yl)phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)F)S(N=CN(C)C)(=O)=O KAPVKSYSBOIXJZ-UHFFFAOYSA-N 0.000 claims 1
- RKIWJHBFPPFMEF-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-(dimethylaminomethylideneamino)sulfonyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N=CN(C)C)(=O)=O RKIWJHBFPPFMEF-UHFFFAOYSA-N 0.000 claims 1
- AGMBSMPRGQFESB-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-(3-fluoropyrazol-1-yl)phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C(C=C1)F)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O AGMBSMPRGQFESB-UHFFFAOYSA-N 0.000 claims 1
- NUIRIRYFAWADKY-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-(4-methylimidazol-1-yl)phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1C=NC(=C1)C)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O NUIRIRYFAWADKY-UHFFFAOYSA-N 0.000 claims 1
- WXXOJGGADMTRMS-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-(4-methylpyrazol-1-yl)phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O WXXOJGGADMTRMS-UHFFFAOYSA-N 0.000 claims 1
- VWBUZNWFISPPHO-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-(4-propan-2-ylpyrazol-1-yl)phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(C)C)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O VWBUZNWFISPPHO-UHFFFAOYSA-N 0.000 claims 1
- ZJHAFSKUIBONBG-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-[4-(2,2,2-trifluoroethylamino)pyrazol-1-yl]phenyl]acetamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(NC(=O)Cc3ccccc3Cl)ccc2-n2cc(NCC(F)(F)F)cn2)c(OC)c1 ZJHAFSKUIBONBG-UHFFFAOYSA-N 0.000 claims 1
- CEOCTVPKOXCATN-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-[4-(2,5-dimethylpyrrolidin-1-yl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)N1C(CCC1C)C)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O CEOCTVPKOXCATN-UHFFFAOYSA-N 0.000 claims 1
- QFWFVJRZFFZIAD-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-[4-(2-methoxyethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)CCOC)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O QFWFVJRZFFZIAD-UHFFFAOYSA-N 0.000 claims 1
- JZMWQTDDRRQFJK-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-pyrazolo[3,4-b]pyridin-2-ylphenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C2N=CC=CC2=C1)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O JZMWQTDDRRQFJK-UHFFFAOYSA-N 0.000 claims 1
- WSVFQMHOJQDNHU-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-pyrazolo[3,4-c]pyridin-2-ylphenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C2C=NC=CC2=C1)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O WSVFQMHOJQDNHU-UHFFFAOYSA-N 0.000 claims 1
- ARTKRNWQJIEISO-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-pyrazolo[4,3-b]pyridin-2-ylphenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C2C(N=CC=C2)=C1)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O ARTKRNWQJIEISO-UHFFFAOYSA-N 0.000 claims 1
- JUTVSOMZGLRXHQ-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-sulfamoyl-2-(trifluoromethyl)-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1c(ccc(NC(=O)Cc2ccccc2Cl)c1C(F)(F)F)-n1cc(cn1)C(F)(F)F JUTVSOMZGLRXHQ-UHFFFAOYSA-N 0.000 claims 1
- GFFKSVRSKNJISM-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[3-sulfamoyl-4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1-n1cnc(n1)C(F)(F)F GFFKSVRSKNJISM-UHFFFAOYSA-N 0.000 claims 1
- QATOWVCRISSBKW-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(2-methoxy-1,3-thiazol-4-yl)-3-sulfamoylphenyl]acetamide Chemical compound COc1nc(cs1)-c1ccc(NC(=O)Cc2ccccc2Cl)cc1S(N)(=O)=O QATOWVCRISSBKW-UHFFFAOYSA-N 0.000 claims 1
- DLPOODQABXLEGI-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(3-cyclopropylpyrazol-1-yl)-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C(C=C1)C1CC1)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O DLPOODQABXLEGI-UHFFFAOYSA-N 0.000 claims 1
- VGQJTRFBPVRRJK-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(4-cyano-1,3-thiazol-2-yl)-3-sulfamoylphenyl]acetamide 2-(2-chlorophenyl)-N-[4-[2-(difluoromethyl)-1,3-thiazol-5-yl]-3-sulfamoylphenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(S1)C(F)F)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC=C(N1)C#N)S(N)(=O)=O VGQJTRFBPVRRJK-UHFFFAOYSA-N 0.000 claims 1
- UMUFLWJJAWFMLD-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(4-cyanopyrazol-1-yl)-3-sulfamoyl-2-(trifluoromethyl)phenyl]acetamide Chemical compound NS(=O)(=O)c1c(ccc(NC(=O)Cc2ccccc2Cl)c1C(F)(F)F)-n1cc(cn1)C#N UMUFLWJJAWFMLD-UHFFFAOYSA-N 0.000 claims 1
- VLGCAGJBFFVXAV-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(4-cyanopyrazol-1-yl)-3-sulfamoylphenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O VLGCAGJBFFVXAV-UHFFFAOYSA-N 0.000 claims 1
- OIOJUHGSQNSGQC-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(4-cyanopyrazol-1-yl)-5-sulfamoyl-2-(trifluoromethyl)phenyl]acetamide 2-(2-chlorophenyl)-N-[3-sulfamoyl-4-[2-(trifluoromethyl)-1,3-thiazol-5-yl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=C(C=C(C(=C1)S(N)(=O)=O)N1N=CC(=C1)C#N)C(F)(F)F.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(S1)C(F)(F)F)S(N)(=O)=O OIOJUHGSQNSGQC-UHFFFAOYSA-N 0.000 claims 1
- PYFFLIYKHFVRHQ-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(4-cyclopropylimidazol-1-yl)-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1C=NC(=C1)C1CC1)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O PYFFLIYKHFVRHQ-UHFFFAOYSA-N 0.000 claims 1
- FGDPMFCYEFTFOU-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(4-methyl-1,3-oxazol-2-yl)-3-sulfamoylphenyl]acetamide 2-(2-chlorophenyl)-N-[3-sulfamoyl-4-[2-(trifluoromethyl)-1,3-thiazol-4-yl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N=C(SC1)C(F)(F)F)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1OC=C(N1)C)S(N)(=O)=O FGDPMFCYEFTFOU-UHFFFAOYSA-N 0.000 claims 1
- QMJCWWFHHFSGBY-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(5-chloropyridin-2-yl)-3-sulfamoylphenyl]acetamide 2-(2-chlorophenyl)-N-[4-(1,2-dimethylimidazol-4-yl)-3-sulfamoylphenyl]acetamide Chemical compound CC1=NC(=CN1C)C2=C(C=C(C=C2)NC(=O)CC3=CC=CC=C3Cl)S(=O)(=O)N.C1=CC=C(C(=C1)CC(=O)NC2=CC(=C(C=C2)C3=NC=C(C=C3)Cl)S(=O)(=O)N)Cl QMJCWWFHHFSGBY-UHFFFAOYSA-N 0.000 claims 1
- DEBYNMZGKRFJFD-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(5-cyano-1-methylpyrrol-2-yl)-3-(dimethylaminomethylideneamino)sulfonylphenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N(C(=CC=1)C#N)C)S(N=CN(C)C)(=O)=O DEBYNMZGKRFJFD-UHFFFAOYSA-N 0.000 claims 1
- MHGYTJHQOUNZDM-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-3-sulfamoylphenyl]acetamide N-[4-[4-(difluoromethyl)pyrazol-1-yl]-3-sulfamoylphenyl]-2-(2-fluorophenyl)acetamide Chemical compound FC(C=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(N)(=O)=O)F.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1OC(=NN1)C1CC1)S(N)(=O)=O MHGYTJHQOUNZDM-UHFFFAOYSA-N 0.000 claims 1
- CETKNPSQOTULQP-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[1-(3-hydroxy-3-methylbutyl)pyrazol-4-yl]-3-sulfamoylphenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NN(C=1)CCC(C)(C)O)S(N)(=O)=O CETKNPSQOTULQP-UHFFFAOYSA-N 0.000 claims 1
- JVFXOPGUOCLKLO-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[1-(difluoromethyl)-5-(trifluoromethyl)pyrazol-4-yl]-3-sulfamoylphenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1-c1cnn(C(F)F)c1C(F)(F)F JVFXOPGUOCLKLO-UHFFFAOYSA-N 0.000 claims 1
- KVMJKCFVZLPEBO-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[1-(difluoromethyl)pyrazol-4-yl]-3-sulfamoyl-2-(trifluoromethyl)phenyl]acetamide Chemical compound NS(=O)(=O)c1c(ccc(NC(=O)Cc2ccccc2Cl)c1C(F)(F)F)-c1cnn(c1)C(F)F KVMJKCFVZLPEBO-UHFFFAOYSA-N 0.000 claims 1
- IMQZZFQCHRTSJI-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[1-(difluoromethyl)pyrazol-4-yl]-5-sulfamoyl-2-(trifluoromethyl)phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)c(cc1-c1cnn(c1)C(F)F)C(F)(F)F IMQZZFQCHRTSJI-UHFFFAOYSA-N 0.000 claims 1
- OPLPCLYSPBXJPG-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[2-(2-hydroxypropan-2-yl)-1,3-thiazol-5-yl]-3-sulfamoylphenyl]acetamide 2-(2-chlorophenyl)-N-[3-sulfamoyl-4-[4-(trifluoromethyl)-1,3-thiazol-2-yl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(S1)C(C)(C)O)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC=C(N1)C(F)(F)F)S(N)(=O)=O OPLPCLYSPBXJPG-UHFFFAOYSA-N 0.000 claims 1
- FBANTQAXGUSKLQ-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]acetamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(NC(=O)Cc3ccccc3Cl)ccc2-n2cnc(n2)C(F)F)c(OC)c1 FBANTQAXGUSKLQ-UHFFFAOYSA-N 0.000 claims 1
- NKRBYPKNEBEFHB-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[4-(2,2-difluoroethyl)pyrazol-1-yl]-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)CC(F)F)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O NKRBYPKNEBEFHB-UHFFFAOYSA-N 0.000 claims 1
- OYWKDMLWQADSHR-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[4-(2,2-difluoroethylamino)pyrazol-1-yl]-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)NCC(F)F)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O OYWKDMLWQADSHR-UHFFFAOYSA-N 0.000 claims 1
- UPLUVTGCHXLFNE-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[4-(3,3-difluoroazetidine-1-carbonyl)pyrazol-1-yl]-3-sulfamoylphenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1-n1cc(cn1)C(=O)N1CC(F)(F)C1 UPLUVTGCHXLFNE-UHFFFAOYSA-N 0.000 claims 1
- ZGMKFEZZAGBGAZ-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[4-(difluoromethyl)pyrazol-1-yl]-3-sulfamoylphenyl]acetamide 2-(2-chlorophenyl)-N-[5-sulfamoyl-6-[4-(trifluoromethyl)pyrazol-1-yl]pyridin-3-yl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC=1C=NC(=C(C1)S(N)(=O)=O)N1N=CC(=C1)C(F)(F)F.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)F)S(N)(=O)=O ZGMKFEZZAGBGAZ-UHFFFAOYSA-N 0.000 claims 1
- DDZDRJBURFLRCD-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[4-[(2,2-difluoroethylamino)methyl]pyrazol-1-yl]-3-sulfamoylphenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)CNCC(F)F)S(N)(=O)=O DDZDRJBURFLRCD-UHFFFAOYSA-N 0.000 claims 1
- CBVBUDSEEGXIRC-IYBDPMFKSA-N 2-(2-chlorophenyl)-N-[4-[4-[(2R,5S)-2,5-dimethylpyrrolidin-1-yl]pyrazol-1-yl]-3-sulfamoylphenyl]acetamide Chemical compound C[C@H]1CC[C@@H](C)N1c1cnn(c1)-c1ccc(NC(=O)Cc2ccccc2Cl)cc1S(N)(=O)=O CBVBUDSEEGXIRC-IYBDPMFKSA-N 0.000 claims 1
- FGKBKRCMQMHDOO-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[4-chloro-3-(trifluoromethyl)pyrazol-1-yl]-3-sulfamoylphenyl]acetamide 2-(2-chlorophenyl)-N-[4-(3,4-dimethylpyrazol-1-yl)-3-sulfamoylphenyl]acetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C(C(=C1)C)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C(C(=C1)Cl)C(F)(F)F)S(N)(=O)=O FGKBKRCMQMHDOO-UHFFFAOYSA-N 0.000 claims 1
- UECHMZCALZYWRD-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[4-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]acetamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(NC(=O)Cc3ccccc3Cl)ccc2-c2nnc(o2)C(F)F)c(OC)c1 UECHMZCALZYWRD-UHFFFAOYSA-N 0.000 claims 1
- MYYIEEXEJSJHFK-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[5-sulfamoyl-2-(trifluoromethyl)-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)c(cc1-n1cc(cn1)C(F)(F)F)C(F)(F)F MYYIEEXEJSJHFK-UHFFFAOYSA-N 0.000 claims 1
- OGFQTGAABVGWOY-UHFFFAOYSA-N 2-(2-chlorophenyl)-N-[6-(4-cyanopyrazol-1-yl)-5-sulfamoylpyridin-3-yl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)cnc1-n1cc(cn1)C#N OGFQTGAABVGWOY-UHFFFAOYSA-N 0.000 claims 1
- IIOPLGGZMXJSJM-UHFFFAOYSA-N 2-(2-chloropyridin-3-yl)-N-[3-sulfamoyl-4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl]acetamide Chemical compound ClC1=NC=CC=C1CC(=O)NC1=CC(=C(C=C1)N1N=C(N=C1)C(F)(F)F)S(N)(=O)=O IIOPLGGZMXJSJM-UHFFFAOYSA-N 0.000 claims 1
- ZAEJKTURZRTOJF-UHFFFAOYSA-N 2-(3-chlorophenyl)-N-[3-sulfamoyl-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl]acetamide 2-(4-methylphenyl)-N-[3-sulfamoyl-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl]acetamide Chemical compound CC1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O.ClC=1C=C(C=CC1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O ZAEJKTURZRTOJF-UHFFFAOYSA-N 0.000 claims 1
- YLCJWKZCOBCZLY-UHFFFAOYSA-N 2-(3-chloropyridin-4-yl)-N-[3-sulfamoyl-4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl]acetamide Chemical compound ClC=1C=NC=CC=1CC(=O)NC1=CC(=C(C=C1)N1N=C(N=C1)C(F)(F)F)S(N)(=O)=O YLCJWKZCOBCZLY-UHFFFAOYSA-N 0.000 claims 1
- VCQVPDREGQJVIV-UHFFFAOYSA-N 2-(3-chloropyridin-4-yl)-N-[4-(4-cyanopyrazol-1-yl)-3-sulfamoylphenyl]acetamide N-[4-(4-cyanopyrazol-1-yl)-3-sulfamoylphenyl]-2-[4-(difluoromethyl)phenyl]acetamide Chemical compound C(#N)C=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)C(F)F)=O)S(N)(=O)=O.ClC=1C=NC=CC1CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O VCQVPDREGQJVIV-UHFFFAOYSA-N 0.000 claims 1
- AYNQNASJBDNENF-UHFFFAOYSA-N 2-(3-cyclopropylpyrazol-1-yl)-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound C1(CC1)C1=NN(C=C1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC AYNQNASJBDNENF-UHFFFAOYSA-N 0.000 claims 1
- IAGDUBGJJVAEGH-UHFFFAOYSA-N 2-(4-bromopyrazol-1-yl)-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound BrC=1C=NN(C=1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC IAGDUBGJJVAEGH-UHFFFAOYSA-N 0.000 claims 1
- WJPIIJHLNLPVBF-UHFFFAOYSA-N 2-(4-chloropyrazol-1-yl)-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound ClC=1C=NN(C=1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC WJPIIJHLNLPVBF-UHFFFAOYSA-N 0.000 claims 1
- YAFALPCGBLOTTA-UHFFFAOYSA-N 2-(4-cyanopyrazol-1-yl)-5-nitrobenzenesulfonamide Chemical compound C(#N)C=1C=NN(C=1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N YAFALPCGBLOTTA-UHFFFAOYSA-N 0.000 claims 1
- SRVNIWZFNZSVBC-UHFFFAOYSA-N 2-(4-cyanopyrazol-1-yl)-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound C(#N)C=1C=NN(C=1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC SRVNIWZFNZSVBC-UHFFFAOYSA-N 0.000 claims 1
- DQRFOSJQFMDSHJ-UHFFFAOYSA-N 2-(4-cyclopropylimidazol-1-yl)-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound C1(CC1)C=1N=CN(C=1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC DQRFOSJQFMDSHJ-UHFFFAOYSA-N 0.000 claims 1
- OOZGQZARSZOUJN-UHFFFAOYSA-N 2-(4-fluorophenyl)-N-[4-(4-fluoropyrazol-1-yl)-3-sulfamoylphenyl]acetamide Chemical compound FC1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)F)S(N)(=O)=O OOZGQZARSZOUJN-UHFFFAOYSA-N 0.000 claims 1
- RKBLYIVQUDOLGU-UHFFFAOYSA-N 2-(5-bromo-4-fluoro-2-methylphenyl)-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound BrC=1C(=CC(=C(C=1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N)(=O)=O)C)F RKBLYIVQUDOLGU-UHFFFAOYSA-N 0.000 claims 1
- QMFDJNHWUUDLNN-UHFFFAOYSA-N 2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound C1(CC1)C1=NC(=NO1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC QMFDJNHWUUDLNN-UHFFFAOYSA-N 0.000 claims 1
- LHCKXYXQCWEGEK-UHFFFAOYSA-N 2-[(2,4-dimethoxyphenyl)methylsulfamoyl]-N'-hydroxy-4-nitrobenzenecarboximidamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])C(N)=NO)C=CC(=C1)OC LHCKXYXQCWEGEK-UHFFFAOYSA-N 0.000 claims 1
- CRYMAXVTMJFTJG-UHFFFAOYSA-N 2-[2-(difluoromethoxy)phenyl]-N-[3-sulfamoyl-4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2OC(F)F)ccc1-n1cnc(n1)C(F)(F)F CRYMAXVTMJFTJG-UHFFFAOYSA-N 0.000 claims 1
- CNVOKKQPLDXRLO-UHFFFAOYSA-N 2-[2-chloro-3-(trifluoromethyl)phenyl]-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C=CC=C1C(F)(F)F)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N)(=O)=O CNVOKKQPLDXRLO-UHFFFAOYSA-N 0.000 claims 1
- RJMISFCPOKWUGV-UHFFFAOYSA-N 2-[2-chloro-3-(trifluoromethyl)phenyl]-N-[4-(4-cyanopyrazol-1-yl)-5-sulfamoyl-2-(trifluoromethyl)phenyl]acetamide Chemical compound ClC1=C(C=CC=C1C(F)(F)F)CC(=O)NC1=C(C=C(C(=C1)S(N)(=O)=O)N1N=CC(=C1)C#N)C(F)(F)F RJMISFCPOKWUGV-UHFFFAOYSA-N 0.000 claims 1
- WTLKONFDBRCXBH-UHFFFAOYSA-N 2-[2-chloro-3-(trifluoromethyl)phenyl]-N-[4-(4-fluoropyrazol-1-yl)-5-sulfamoyl-2-(trifluoromethyl)phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2cccc(c2Cl)C(F)(F)F)c(cc1-n1cc(F)cn1)C(F)(F)F WTLKONFDBRCXBH-UHFFFAOYSA-N 0.000 claims 1
- HFTNBRFUQUZWKU-UHFFFAOYSA-N 2-[2-chloro-3-(trifluoromethyl)phenyl]-N-[4-[1-(difluoromethyl)pyrazol-4-yl]-3-sulfamoylphenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2cccc(c2Cl)C(F)(F)F)ccc1-c1cnn(c1)C(F)F HFTNBRFUQUZWKU-UHFFFAOYSA-N 0.000 claims 1
- JXRJLJXZDACBRJ-UHFFFAOYSA-N 2-[2-chloro-3-(trifluoromethyl)phenyl]-N-[5-sulfamoyl-2-(trifluoromethyl)-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2cccc(c2Cl)C(F)(F)F)c(cc1-n1cc(cn1)C(F)(F)F)C(F)(F)F JXRJLJXZDACBRJ-UHFFFAOYSA-N 0.000 claims 1
- VFAIDMARDPCQJK-UHFFFAOYSA-N 2-[2-chloro-4-(trifluoromethyl)phenyl]-N-[4-(4-fluoropyrazol-1-yl)-5-sulfamoyl-2-(trifluoromethyl)phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccc(cc2Cl)C(F)(F)F)c(cc1-n1cc(F)cn1)C(F)(F)F VFAIDMARDPCQJK-UHFFFAOYSA-N 0.000 claims 1
- RTIQZJNAAVIFJB-UHFFFAOYSA-N 2-[2-chloro-5-(trifluoromethyl)phenyl]-N-[4-(4-cyanopyrazol-1-yl)-3-sulfamoylphenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2cc(ccc2Cl)C(F)(F)F)ccc1-n1cc(cn1)C#N RTIQZJNAAVIFJB-UHFFFAOYSA-N 0.000 claims 1
- WJKRZGMDVZRFDQ-UHFFFAOYSA-N 2-[2-chloro-5-(trifluoromethyl)phenyl]-N-[4-(4-cyanopyrazol-1-yl)-5-sulfamoyl-2-(trifluoromethyl)phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2cc(ccc2Cl)C(F)(F)F)c(cc1-n1cc(cn1)C#N)C(F)(F)F WJKRZGMDVZRFDQ-UHFFFAOYSA-N 0.000 claims 1
- JIQFWRDMOKZIBK-UHFFFAOYSA-N 2-[2-chloro-5-(trifluoromethyl)phenyl]-N-[4-(4-fluoropyrazol-1-yl)-5-sulfamoyl-2-(trifluoromethyl)phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2cc(ccc2Cl)C(F)(F)F)c(cc1-n1cc(F)cn1)C(F)(F)F JIQFWRDMOKZIBK-UHFFFAOYSA-N 0.000 claims 1
- HSXYLAUZXDWLSC-UHFFFAOYSA-N 2-[2-chloro-5-(trifluoromethyl)phenyl]-N-[5-sulfamoyl-2-(trifluoromethyl)-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2cc(ccc2Cl)C(F)(F)F)c(cc1-n1cc(cn1)C(F)(F)F)C(F)(F)F HSXYLAUZXDWLSC-UHFFFAOYSA-N 0.000 claims 1
- GAWPFWMTCTUNSG-UHFFFAOYSA-N 2-[2-chloro-6-(trifluoromethyl)phenyl]-N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide Chemical compound ClC1=C(C(=CC=C1)C(F)(F)F)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(F)(F)F)S(N)(=O)=O GAWPFWMTCTUNSG-UHFFFAOYSA-N 0.000 claims 1
- BEJMEVSHQZJSIE-UHFFFAOYSA-N 2-[2-chloro-6-(trifluoromethyl)phenyl]-N-[4-(4-fluoropyrazol-1-yl)-5-sulfamoyl-2-(trifluoromethyl)phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2c(Cl)cccc2C(F)(F)F)c(cc1-n1cc(F)cn1)C(F)(F)F BEJMEVSHQZJSIE-UHFFFAOYSA-N 0.000 claims 1
- NCGGFAGHZCUWIL-UHFFFAOYSA-N 2-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound FC(C1=NN(C=N1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC)F NCGGFAGHZCUWIL-UHFFFAOYSA-N 0.000 claims 1
- BROGVWCNKQVSPW-UHFFFAOYSA-N 2-[4-(2,2-difluoroethyl)pyrazol-1-yl]-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound FC(CC=1C=NN(C=1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC)F BROGVWCNKQVSPW-UHFFFAOYSA-N 0.000 claims 1
- JBHSUNYTQWPKQF-UHFFFAOYSA-N 2-[4-(2,2-difluoroethylamino)pyrazol-1-yl]-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(ccc2-n2cc(NCC(F)F)cn2)[N+]([O-])=O)c(OC)c1 JBHSUNYTQWPKQF-UHFFFAOYSA-N 0.000 claims 1
- XPWAYPKRIXTZSQ-UHFFFAOYSA-N 2-[4-(difluoromethyl)phenyl]-N-[3-sulfamoyl-4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccc(cc2)C(F)F)ccc1-n1cnc(n1)C(F)(F)F XPWAYPKRIXTZSQ-UHFFFAOYSA-N 0.000 claims 1
- HNCWCXOCLSGPKY-UHFFFAOYSA-N 2-[4-(difluoromethyl)phenyl]-N-[3-sulfamoyl-4-[4-(trifluoromethyl)triazol-1-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccc(cc2)C(F)F)ccc1-n1cc(nn1)C(F)(F)F HNCWCXOCLSGPKY-UHFFFAOYSA-N 0.000 claims 1
- CYQGGSUVQBJWKQ-UHFFFAOYSA-N 2-[4-(difluoromethyl)phenyl]-N-[3-sulfamoyl-4-[4-(trifluoromethyl)triazol-2-yl]phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccc(cc2)C(F)F)ccc1-n1ncc(n1)C(F)(F)F CYQGGSUVQBJWKQ-UHFFFAOYSA-N 0.000 claims 1
- UVQLOPYPYIJHDQ-UHFFFAOYSA-N 2-[4-[(2,2-difluoroethylamino)methyl]pyrazol-1-yl]-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound FC(CNCC=1C=NN(C=1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC)F UVQLOPYPYIJHDQ-UHFFFAOYSA-N 0.000 claims 1
- ASMUOTPBGOIPMM-UHFFFAOYSA-N 2-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound FC(C1=NN=C(O1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC)F ASMUOTPBGOIPMM-UHFFFAOYSA-N 0.000 claims 1
- IWJCPJRZFKZSLW-UHFFFAOYSA-N 2-bromo-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound BrC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC IWJCPJRZFKZSLW-UHFFFAOYSA-N 0.000 claims 1
- LAKKISPSJNIBMM-UHFFFAOYSA-N 2-chloro-N-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzenesulfonamide Chemical compound ClC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC LAKKISPSJNIBMM-UHFFFAOYSA-N 0.000 claims 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- TXUYLTDTYPZKGA-UHFFFAOYSA-N 5-amino-2-(2,5-dimethylpyrazol-3-yl)benzenesulfonamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)N)C1=CC(=NN1C)C TXUYLTDTYPZKGA-UHFFFAOYSA-N 0.000 claims 1
- GXVONCAUEHEILG-UHFFFAOYSA-N 5-amino-2-(4-bromopyrazol-1-yl)-N-[(2,4-dimethoxyphenyl)methyl]benzenesulfonamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC)N1N=CC(=C1)Br GXVONCAUEHEILG-UHFFFAOYSA-N 0.000 claims 1
- LOZPZEISDSQBCS-UHFFFAOYSA-N 5-amino-2-(4-chloropyrazol-1-yl)-N-[(2,4-dimethoxyphenyl)methyl]benzenesulfonamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC)N1N=CC(=C1)Cl LOZPZEISDSQBCS-UHFFFAOYSA-N 0.000 claims 1
- DISQBDOOHXDYNE-UHFFFAOYSA-N 5-amino-2-[1-(2-methoxyethyl)pyrazol-4-yl]benzenesulfonamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)N)C=1C=NN(C=1)CCOC DISQBDOOHXDYNE-UHFFFAOYSA-N 0.000 claims 1
- ZVXHXAJVFXYYPH-UHFFFAOYSA-N 5-amino-2-[2-methyl-5-(trifluoromethyl)pyrazol-3-yl]benzenesulfonamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)N)C1=CC(=NN1C)C(F)(F)F ZVXHXAJVFXYYPH-UHFFFAOYSA-N 0.000 claims 1
- NDVOMHXVGAEGAX-UHFFFAOYSA-N 5-amino-N-[(2,4-dimethoxyphenyl)methyl]-2-(4-fluoropyrazol-1-yl)benzenesulfonamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC)N1N=CC(=C1)F NDVOMHXVGAEGAX-UHFFFAOYSA-N 0.000 claims 1
- NCAGCDHIUXXOPI-UHFFFAOYSA-N 5-amino-N-[(2,4-dimethoxyphenyl)methyl]-2-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]benzenesulfonamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC)N1N=C(N=C1)C(F)(F)F NCAGCDHIUXXOPI-UHFFFAOYSA-N 0.000 claims 1
- WGYWUNGLIRGTPN-UHFFFAOYSA-N 5-amino-N-[(2,4-dimethoxyphenyl)methyl]-2-[4-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC)N1N=CC(=C1)C(F)(F)F WGYWUNGLIRGTPN-UHFFFAOYSA-N 0.000 claims 1
- CZLNHOQQGWYLQT-UHFFFAOYSA-N 5-amino-N-[(2,4-dimethoxyphenyl)methyl]-2-phenylbenzenesulfonamide Chemical compound NC=1C=C(C(=CC=1)C1=CC=CC=C1)S(=O)(=O)NCC1=C(C=C(C=C1)OC)OC CZLNHOQQGWYLQT-UHFFFAOYSA-N 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 208000036487 Arthropathies Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000025978 Athletic injury Diseases 0.000 claims 1
- 208000008035 Back Pain Diseases 0.000 claims 1
- 206010004663 Biliary colic Diseases 0.000 claims 1
- IHXBXDGQNDPWAX-UHFFFAOYSA-N BrC1=NN(C=C1C#N)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(N)(=O)=O.C(C)(C)(C)C1=NN(C=C1C#N)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(N)(=O)=O Chemical compound BrC1=NN(C=C1C#N)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(N)(=O)=O.C(C)(C)(C)C1=NN(C=C1C#N)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(N)(=O)=O IHXBXDGQNDPWAX-UHFFFAOYSA-N 0.000 claims 1
- FQKDLFLMJNPSDV-UHFFFAOYSA-N C1(CC1)C1=NN=C(O1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(N)(=O)=O.CN1N=C(C(=C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(N)(=O)=O)C Chemical compound C1(CC1)C1=NN=C(O1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(N)(=O)=O.CN1N=C(C(=C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(N)(=O)=O)C FQKDLFLMJNPSDV-UHFFFAOYSA-N 0.000 claims 1
- 206010058019 Cancer Pain Diseases 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- DYTQUHOEUQEFKR-UHFFFAOYSA-N ClC1=C(C(=CC(=C1)F)F)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O.ClC1=C(C(=CC=C1)OC)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O Chemical compound ClC1=C(C(=CC(=C1)F)F)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O.ClC1=C(C(=CC=C1)OC)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O DYTQUHOEUQEFKR-UHFFFAOYSA-N 0.000 claims 1
- HDECVDABJPQPHU-UHFFFAOYSA-N ClC1=C(C=C(C=C1)O)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O.ClC1=C(C=CC(=C1)O)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O Chemical compound ClC1=C(C=C(C=C1)O)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O.ClC1=C(C=CC(=C1)O)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O HDECVDABJPQPHU-UHFFFAOYSA-N 0.000 claims 1
- MQTCCMVTTRDWLY-UHFFFAOYSA-N ClC1=C(C=CC(=C1)Cl)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O.FC=1C=C(C=CC1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O Chemical compound ClC1=C(C=CC(=C1)Cl)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O.FC=1C=C(C=CC1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O MQTCCMVTTRDWLY-UHFFFAOYSA-N 0.000 claims 1
- CTHWQWMJBQMOEV-UHFFFAOYSA-N ClC1=C(C=CC=C1)C(C(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O)O.ClC1=C(C(=CC=C1)O)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)C(C(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O)O.ClC1=C(C(=CC=C1)O)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O CTHWQWMJBQMOEV-UHFFFAOYSA-N 0.000 claims 1
- CFKGCVFXXCZZAZ-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=C(C=C(C(=C1)S(N)(=O)=O)C=1C=NN(C1)C(F)F)F.ClC1=C(C=CC=C1)CC(=O)NC1=C(C(=C(C=C1)C=1C=NN(C1)C(F)F)S(N)(=O)=O)F Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=C(C=C(C(=C1)S(N)(=O)=O)C=1C=NN(C1)C(F)F)F.ClC1=C(C=CC=C1)CC(=O)NC1=C(C(=C(C=C1)C=1C=NN(C1)C(F)F)S(N)(=O)=O)F CFKGCVFXXCZZAZ-UHFFFAOYSA-N 0.000 claims 1
- WQZPKTNKLOMCDI-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CC=NC=C1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC(=CN1)C)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CC=NC=C1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC(=CN1)C)S(N)(=O)=O WQZPKTNKLOMCDI-UHFFFAOYSA-N 0.000 claims 1
- WKSSMJLSKACTIT-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CC=NS1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N=C(SC1)N(C)C)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CC=NS1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N=C(SC1)N(C)C)S(N)(=O)=O WKSSMJLSKACTIT-UHFFFAOYSA-N 0.000 claims 1
- BGIFBLDIRQWKBP-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(O1)C1CC1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=NOC(=C1)C1CC1)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(O1)C1CC1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=NOC(=C1)C1CC1)S(N)(=O)=O BGIFBLDIRQWKBP-UHFFFAOYSA-N 0.000 claims 1
- CZVPYWJZEZTASH-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(S1)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(S1)OC)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(S1)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(S1)OC)S(N)(=O)=O CZVPYWJZEZTASH-UHFFFAOYSA-N 0.000 claims 1
- LSIUADCNXBYJDA-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N(C(=CC1)C#N)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN(C=C1)C)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N(C(=CC1)C#N)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN(C=C1)C)S(N)(=O)=O LSIUADCNXBYJDA-UHFFFAOYSA-N 0.000 claims 1
- VTCRNPFIQRPLFS-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N=C(SC1)C1CC1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(S1)C1CC1)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N=C(SC1)C1CC1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN=C(S1)C1CC1)S(N)(=O)=O VTCRNPFIQRPLFS-UHFFFAOYSA-N 0.000 claims 1
- UPYFAWKKFQTMOF-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N=CSC1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N=C(SC1)C(C)(C)O)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N=CSC1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1N=C(SC1)C(C)(C)O)S(N)(=O)=O UPYFAWKKFQTMOF-UHFFFAOYSA-N 0.000 claims 1
- OAMFDLDUVMEXMJ-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC(=CN1)N1CCOCC1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC=C(N1)N1CCOCC1)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC(=CN1)N1CCOCC1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC=C(N1)N1CCOCC1)S(N)(=O)=O OAMFDLDUVMEXMJ-UHFFFAOYSA-N 0.000 claims 1
- DUQLEFVLISHDNY-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC=C(N1)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CC(=NS1)C)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC=C(N1)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CC(=NS1)C)S(N)(=O)=O DUQLEFVLISHDNY-UHFFFAOYSA-N 0.000 claims 1
- OXFAFLBQDBAGAC-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC=CN1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NSC1)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1SC=CN1)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NSC1)S(N)(=O)=O OXFAFLBQDBAGAC-UHFFFAOYSA-N 0.000 claims 1
- OOTBLHSYLUNNHR-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1C=NC=2C1=NC=CC2)S(N)(=O)=O.BrC=2N=CN(C2)C2=C(C=C(C=C2)NC(CC2=C(C=CC=C2)Cl)=O)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1C=NC=2C1=NC=CC2)S(N)(=O)=O.BrC=2N=CN(C2)C2=C(C=C(C=C2)NC(CC2=C(C=CC=C2)Cl)=O)S(N)(=O)=O OOTBLHSYLUNNHR-UHFFFAOYSA-N 0.000 claims 1
- PJXWKOBXMVTEHC-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C(C(=C1)C#N)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1C)C#N)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C(C(=C1)C#N)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1C)C#N)S(N)(=O)=O PJXWKOBXMVTEHC-UHFFFAOYSA-N 0.000 claims 1
- WRRACMSWJPFWNJ-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C(C=C1C)O)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C(C=C1C)C#N)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C(C=C1C)O)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C(C=C1C)C#N)S(N)(=O)=O WRRACMSWJPFWNJ-UHFFFAOYSA-N 0.000 claims 1
- IWAOZYVACLPKKK-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C2C(=N1)C=C(C=C2F)F)S(N)(=O)=O.ClC2=C(C=CC=C2)CC(=O)NC2=CC(=C(C=C2)N2N=NC1=C2C=C(C=C1F)F)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=C2C(=N1)C=C(C=C2F)F)S(N)(=O)=O.ClC2=C(C=CC=C2)CC(=O)NC2=CC(=C(C=C2)N2N=NC1=C2C=C(C=C1F)F)S(N)(=O)=O IWAOZYVACLPKKK-UHFFFAOYSA-N 0.000 claims 1
- DJYUIZLNOSASHP-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)N1CCCC1)S(N)(=O)=O.N1(CCC1)C(=O)C=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)N1CCCC1)S(N)(=O)=O.N1(CCC1)C(=O)C=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(N)(=O)=O DJYUIZLNOSASHP-UHFFFAOYSA-N 0.000 claims 1
- AJWSYTQWVNIXNY-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(C)(C)O)S(N)(=O)=O.FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(C)(C)O)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(C)(C)O)S(N)(=O)=O.FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(C)(C)O)S(N)(=O)=O AJWSYTQWVNIXNY-UHFFFAOYSA-N 0.000 claims 1
- SLCLDYRDSHSKSL-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C1CC1)S(N)(=O)=O.FC(C1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)F)S(N)(=O)=O)F Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C1CC1)S(N)(=O)=O.FC(C1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)F)S(N)(=O)=O)F SLCLDYRDSHSKSL-UHFFFAOYSA-N 0.000 claims 1
- FECKTLXKWSNEAD-UHFFFAOYSA-N ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC=C1)S(N)(=O)=O.ClC=1C(=NN(C1C)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(N)(=O)=O)C Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC=C1)S(N)(=O)=O.ClC=1C(=NN(C1C)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(N)(=O)=O)C FECKTLXKWSNEAD-UHFFFAOYSA-N 0.000 claims 1
- FCODEGTZKTVTIX-UHFFFAOYSA-N ClC1=C(C=CC=C1O)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)N)S(N)(=O)=O Chemical compound ClC1=C(C=CC=C1O)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C#N)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)N)S(N)(=O)=O FCODEGTZKTVTIX-UHFFFAOYSA-N 0.000 claims 1
- BUPFUMIMVKSFSK-UHFFFAOYSA-N ClC1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)N1CC(CC1)(F)F)S(N)(=O)=O Chemical compound ClC1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)N1CC(CC1)(F)F)S(N)(=O)=O BUPFUMIMVKSFSK-UHFFFAOYSA-N 0.000 claims 1
- GVDFEUDUPMXNSK-UHFFFAOYSA-N ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)C(F)(F)F)Cl)=O)S(N)(=O)=O.ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)C(F)F)=O)S(N)(=O)=O Chemical compound ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)C(F)(F)F)Cl)=O)S(N)(=O)=O.ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)C(F)F)=O)S(N)(=O)=O GVDFEUDUPMXNSK-UHFFFAOYSA-N 0.000 claims 1
- YHYGFTAIVUOPAC-UHFFFAOYSA-N ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)F)F)=O)S(N)(=O)=O.ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)Cl)Cl)=O)S(N)(=O)=O Chemical compound ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)F)F)=O)S(N)(=O)=O.ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)Cl)Cl)=O)S(N)(=O)=O YHYGFTAIVUOPAC-UHFFFAOYSA-N 0.000 claims 1
- QGCACPFXSDJAGL-UHFFFAOYSA-N ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)OC)F)=O)S(N)(=O)=O.ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)C)F)=O)S(N)(=O)=O Chemical compound ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)OC)F)=O)S(N)(=O)=O.ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)C)F)=O)S(N)(=O)=O QGCACPFXSDJAGL-UHFFFAOYSA-N 0.000 claims 1
- DMBGHXCGBPFGPS-UHFFFAOYSA-N ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(N)(=O)=O.ClC1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC(=CC1)Cl)S(N)(=O)=O Chemical compound ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(N)(=O)=O.ClC1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC(=CC1)Cl)S(N)(=O)=O DMBGHXCGBPFGPS-UHFFFAOYSA-N 0.000 claims 1
- DXKVXMPRBCHEFC-UHFFFAOYSA-N ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=CC(=C(C=C1)F)F)=O)S(N)(=O)=O.BrC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC(=CC1)Cl)S(N)(=O)=O Chemical compound ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=CC(=C(C=C1)F)F)=O)S(N)(=O)=O.BrC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC(=CC1)Cl)S(N)(=O)=O DXKVXMPRBCHEFC-UHFFFAOYSA-N 0.000 claims 1
- QYRFKLGFKWPCTB-UHFFFAOYSA-N ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)OC)=O)S(N)(=O)=O.ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)C)=O)S(N)(=O)=O Chemical compound ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)OC)=O)S(N)(=O)=O.ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)C)=O)S(N)(=O)=O QYRFKLGFKWPCTB-UHFFFAOYSA-N 0.000 claims 1
- 208000006561 Cluster Headache Diseases 0.000 claims 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 claims 1
- 208000032170 Congenital Abnormalities Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010061619 Deformity Diseases 0.000 claims 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- PLJIGXREUNVJQQ-UHFFFAOYSA-N FC(C1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O)F.FC1=C(C=CC(=C1)OC)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O Chemical compound FC(C1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O)F.FC1=C(C=CC(=C1)OC)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O PLJIGXREUNVJQQ-UHFFFAOYSA-N 0.000 claims 1
- YCUWOBHBBJPBLB-UHFFFAOYSA-N FC(N1N=CC(=C1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)F)=O)S(N)(=O)=O)F.FC(N1N=CC(=C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)OC)=O)S(N)(=O)=O)F Chemical compound FC(N1N=CC(=C1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)F)=O)S(N)(=O)=O)F.FC(N1N=CC(=C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)OC)=O)S(N)(=O)=O)F YCUWOBHBBJPBLB-UHFFFAOYSA-N 0.000 claims 1
- CHNQNKPRDYQFAK-UHFFFAOYSA-N FC1=C(C=CC(=C1)C)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O.COC1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O Chemical compound FC1=C(C=CC(=C1)C)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O.COC1=CC=C(C=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O CHNQNKPRDYQFAK-UHFFFAOYSA-N 0.000 claims 1
- NGAGNQLEZPRIRE-UHFFFAOYSA-N FC1=C(C=CC(=C1)C)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)F)S(N)(=O)=O.ClC1=C(C=CC(=C1)Cl)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)F)S(N)(=O)=O Chemical compound FC1=C(C=CC(=C1)C)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)F)S(N)(=O)=O.ClC1=C(C=CC(=C1)Cl)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)F)S(N)(=O)=O NGAGNQLEZPRIRE-UHFFFAOYSA-N 0.000 claims 1
- IINODNYFQSFYIK-UHFFFAOYSA-N FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NN(C1)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NN(C1)C1COC1)S(N)(=O)=O Chemical compound FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NN(C1)C)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C=1C=NN(C1)C1COC1)S(N)(=O)=O IINODNYFQSFYIK-UHFFFAOYSA-N 0.000 claims 1
- HLWWPKHWGCSJBS-UHFFFAOYSA-N FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)OCC)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)OCC)S(N)(=O)=O Chemical compound FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)OCC)S(N)(=O)=O.ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)OCC)S(N)(=O)=O HLWWPKHWGCSJBS-UHFFFAOYSA-N 0.000 claims 1
- WNZPYZHSEDXTDR-UHFFFAOYSA-N FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=NC(=C1)C(F)(F)F)S(N)(=O)=O.FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=N1)C(F)(F)F)S(N)(=O)=O Chemical compound FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=NC(=C1)C(F)(F)F)S(N)(=O)=O.FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=N1)C(F)(F)F)S(N)(=O)=O WNZPYZHSEDXTDR-UHFFFAOYSA-N 0.000 claims 1
- ORFCFMJEFPPOAN-UHFFFAOYSA-N FC1=C(C=CC=C1F)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)F)S(N)(=O)=O.FC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)C)=O)S(N)(=O)=O Chemical compound FC1=C(C=CC=C1F)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)F)S(N)(=O)=O.FC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)C)=O)S(N)(=O)=O ORFCFMJEFPPOAN-UHFFFAOYSA-N 0.000 claims 1
- PMLKNBSWONUQGC-UHFFFAOYSA-N FC1=CC(=CC=2N(N=NC21)C2=C(C=C(C=C2)NC(CC2=C(C=CC=C2)F)=O)S(N)(=O)=O)F.FC2=CC(=CC1=NN(N=C12)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(N)(=O)=O)F Chemical compound FC1=CC(=CC=2N(N=NC21)C2=C(C=C(C=C2)NC(CC2=C(C=CC=C2)F)=O)S(N)(=O)=O)F.FC2=CC(=CC1=NN(N=C12)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(N)(=O)=O)F PMLKNBSWONUQGC-UHFFFAOYSA-N 0.000 claims 1
- ZBPZBZIYAYATOL-UHFFFAOYSA-N FC=1C=C(C=C(C1)F)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O.FC=1C=C(C=CC1F)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O Chemical compound FC=1C=C(C=C(C1)F)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O.FC=1C=C(C=CC1F)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O ZBPZBZIYAYATOL-UHFFFAOYSA-N 0.000 claims 1
- BVLDKMDEQWHCKH-UHFFFAOYSA-N FC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=CC(=CC=C1)C)=O)S(N)(=O)=O.FC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)O)=O)S(N)(=O)=O Chemical compound FC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=CC(=CC=C1)C)=O)S(N)(=O)=O.FC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)O)=O)S(N)(=O)=O BVLDKMDEQWHCKH-UHFFFAOYSA-N 0.000 claims 1
- WSNMBNYIFVBAEA-UHFFFAOYSA-N FC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)OC)=O)S(N)(=O)=O.FC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)C)=O)S(N)(=O)=O Chemical compound FC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)OC)=O)S(N)(=O)=O.FC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=CC=C(C=C1)C)=O)S(N)(=O)=O WSNMBNYIFVBAEA-UHFFFAOYSA-N 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 208000004454 Hyperalgesia Diseases 0.000 claims 1
- 208000035154 Hyperesthesia Diseases 0.000 claims 1
- 208000012659 Joint disease Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- CKVXGMJOUWQLJU-UHFFFAOYSA-N N'-(2-bromo-5-nitrophenyl)sulfonyl-N,N-dimethylmethanimidamide Chemical compound BrC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N=CN(C)C CKVXGMJOUWQLJU-UHFFFAOYSA-N 0.000 claims 1
- VQWLDQLWLKIWCP-UHFFFAOYSA-N N'-(2-chloro-5-nitrophenyl)sulfonyl-N,N-dimethylmethanimidamide Chemical compound CN(C)C=NS(=O)(=O)c1cc(ccc1Cl)[N+]([O-])=O VQWLDQLWLKIWCP-UHFFFAOYSA-N 0.000 claims 1
- RUVLBIXFURFMJJ-UHFFFAOYSA-N N'-(5-amino-2-bromophenyl)sulfonyl-N,N-dimethylmethanimidamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)N=CN(C)C)Br RUVLBIXFURFMJJ-UHFFFAOYSA-N 0.000 claims 1
- HBJNPDDROBCLAW-UHFFFAOYSA-N N'-(5-bromo-2-chloropyridin-3-yl)sulfonyl-N,N-dimethylmethanimidamide Chemical compound BrC=1C=C(C(=NC=1)Cl)S(=O)(=O)N=CN(C)C HBJNPDDROBCLAW-UHFFFAOYSA-N 0.000 claims 1
- GQIJNEFFTPHMSR-UHFFFAOYSA-N N'-[2-[1-(difluoromethyl)pyrazol-4-yl]-5-nitrophenyl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound FC(N1N=CC(=C1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N=CN(C)C)F GQIJNEFFTPHMSR-UHFFFAOYSA-N 0.000 claims 1
- CUVYQCCGXRXAAU-UHFFFAOYSA-N N'-[2-[4-(difluoromethyl)pyrazol-1-yl]-5-nitrophenyl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound FC(C=1C=NN(C=1)C1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N=CN(C)C)F CUVYQCCGXRXAAU-UHFFFAOYSA-N 0.000 claims 1
- GTCZRQNXQAIUDU-UHFFFAOYSA-N N'-[5-(benzhydrylideneamino)-2-(1-methylpyrazol-4-yl)pyridin-3-yl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound CN(C)C=NS(=O)(=O)C=1C(=NC=C(C=1)N=C(C1=CC=CC=C1)C1=CC=CC=C1)C=1C=NN(C=1)C GTCZRQNXQAIUDU-UHFFFAOYSA-N 0.000 claims 1
- JZOPGWSAQUKCMT-UHFFFAOYSA-N N'-[5-(benzhydrylideneamino)-2-[1-(difluoromethyl)pyrazol-4-yl]pyridin-3-yl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound CN(C)C=NS(=O)(=O)C1=CC(=CN=C1C1=CN(N=C1)C(F)F)N=C(C1=CC=CC=C1)C1=CC=CC=C1 JZOPGWSAQUKCMT-UHFFFAOYSA-N 0.000 claims 1
- ZMPYUEWRNCTEER-UHFFFAOYSA-N N'-[5-(benzhydrylideneamino)-2-[5-(trifluoromethyl)pyridin-3-yl]pyridin-3-yl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound CN(C)C=NS(=O)(=O)C=1C(=NC=C(C=1)N=C(C1=CC=CC=C1)C1=CC=CC=C1)C=1C=NC=C(C=1)C(F)(F)F ZMPYUEWRNCTEER-UHFFFAOYSA-N 0.000 claims 1
- VSMAJIVIUMQVME-UHFFFAOYSA-N N'-[5-(benzhydrylideneamino)-2-chloropyridin-3-yl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound ClC1=NC=C(C=C1S(=O)(=O)N=CN(C)C)N=C(C1=CC=CC=C1)C1=CC=CC=C1 VSMAJIVIUMQVME-UHFFFAOYSA-N 0.000 claims 1
- QZMNZYFLTWDPDH-UHFFFAOYSA-N N'-[5-amino-2-(1-cyclopropylpyrazol-4-yl)phenyl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound CN(C)C=NS(=O)(=O)C1=C(C=CC(N)=C1)C1=CN(N=C1)C1CC1 QZMNZYFLTWDPDH-UHFFFAOYSA-N 0.000 claims 1
- LBWJADPZLUDYEM-UHFFFAOYSA-N N'-[5-amino-2-(1-methylpyrazol-4-yl)pyridin-3-yl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound NC=1C=C(C(=NC=1)C=1C=NN(C=1)C)S(=O)(=O)N=CN(C)C LBWJADPZLUDYEM-UHFFFAOYSA-N 0.000 claims 1
- YJQSJUMSLOVTMZ-UHFFFAOYSA-N N'-[5-amino-2-(4-bromopyrazol-1-yl)pyridin-3-yl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound NC=1C=C(C(=NC=1)N1N=CC(=C1)Br)S(=O)(=O)N=CN(C)C YJQSJUMSLOVTMZ-UHFFFAOYSA-N 0.000 claims 1
- SKFNQLDSGZJIQS-UHFFFAOYSA-N N'-[5-amino-2-(4-fluoropyrazol-1-yl)pyridin-3-yl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound NC=1C=C(C(=NC=1)N1N=CC(=C1)F)S(=O)(=O)N=CN(C)C SKFNQLDSGZJIQS-UHFFFAOYSA-N 0.000 claims 1
- GXESORXLPVRHHR-UHFFFAOYSA-N N'-[5-amino-2-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)phenyl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)N=CN(C)C)C=1OC(=NN=1)C1CC1 GXESORXLPVRHHR-UHFFFAOYSA-N 0.000 claims 1
- COLNGYFINSWYAN-UHFFFAOYSA-N N'-[5-amino-2-[1-(difluoromethyl)pyrazol-4-yl]phenyl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound CN(C)C=NS(=O)(=O)C1=C(C=CC(N)=C1)C1=CN(N=C1)C(F)F COLNGYFINSWYAN-UHFFFAOYSA-N 0.000 claims 1
- ONFBKVZMJNBMFG-UHFFFAOYSA-N N'-[5-amino-2-[1-(oxan-2-yl)pyrazol-4-yl]phenyl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)N=CN(C)C)C=1C=NN(C=1)C1OCCCC1 ONFBKVZMJNBMFG-UHFFFAOYSA-N 0.000 claims 1
- YHJFAYUVRXLGEX-UHFFFAOYSA-N N'-[5-amino-2-[4-(trifluoromethyl)pyrazol-1-yl]pyridin-3-yl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound NC=1C=C(C(=NC=1)N1N=CC(=C1)C(F)(F)F)S(=O)(=O)N=CN(C)C YHJFAYUVRXLGEX-UHFFFAOYSA-N 0.000 claims 1
- QZOKKTLPXFUNSR-UHFFFAOYSA-N N'-[5-amino-2-[5-(trifluoromethyl)pyridin-3-yl]phenyl]sulfonyl-N,N-dimethylmethanimidamide Chemical compound NC=1C=CC(=C(C=1)S(=O)(=O)N=CN(C)C)C=1C=NC=C(C=1)C(F)(F)F QZOKKTLPXFUNSR-UHFFFAOYSA-N 0.000 claims 1
- QZPSVZKPAPWFEZ-UHFFFAOYSA-N N,N-dimethyl-N'-[5-nitro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]sulfonylmethanimidamide Chemical compound CN(C)C=NS(=O)(=O)C1=C(C=CC(=C1)[N+](=O)[O-])N1N=NC(=C1)C(F)(F)F QZPSVZKPAPWFEZ-UHFFFAOYSA-N 0.000 claims 1
- RYQXFGBLHYGUDW-UHFFFAOYSA-N N,N-dimethyl-N'-[5-nitro-2-[4-(trifluoromethyl)triazol-2-yl]phenyl]sulfonylmethanimidamide Chemical compound CN(C)C=NS(=O)(=O)C1=C(C=CC(=C1)[N+](=O)[O-])N1N=CC(=N1)C(F)(F)F RYQXFGBLHYGUDW-UHFFFAOYSA-N 0.000 claims 1
- JARRFDWLVLTEDR-UHFFFAOYSA-N N,N-dimethyl-N'-[5-nitro-2-[5-(trifluoromethyl)pyridin-3-yl]phenyl]sulfonylmethanimidamide Chemical compound CN(C)C=NS(=O)(=O)c1cc(ccc1-c1cncc(c1)C(F)(F)F)[N+]([O-])=O JARRFDWLVLTEDR-UHFFFAOYSA-N 0.000 claims 1
- GHMAZEAGIMNETL-UHFFFAOYSA-N N-(4-bromo-3-sulfamoylphenyl)-2-(2-chlorophenyl)acetamide Chemical compound BrC1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(N)(=O)=O GHMAZEAGIMNETL-UHFFFAOYSA-N 0.000 claims 1
- NHHHGJAEANIKDH-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-2-(3-fluoropyrazol-1-yl)-5-nitrobenzenesulfonamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(ccc2-n2ccc(F)n2)[N+]([O-])=O)c(OC)c1 NHHHGJAEANIKDH-UHFFFAOYSA-N 0.000 claims 1
- QMEHZGCDFQCIMC-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-2-(3-methoxy-1,2,4-triazol-1-yl)-5-nitrobenzenesulfonamide Chemical compound COc1ncn(n1)-c1ccc(cc1S(=O)(=O)NCc1ccc(OC)cc1OC)[N+]([O-])=O QMEHZGCDFQCIMC-UHFFFAOYSA-N 0.000 claims 1
- JUYSSCPRPIERFL-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-2-(4-fluoropyrazol-1-yl)-5-nitrobenzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=CC(=C2)F)C=CC(=C1)OC JUYSSCPRPIERFL-UHFFFAOYSA-N 0.000 claims 1
- PKCHYFWKPIEVHP-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-2-(4-methylimidazol-1-yl)-5-nitrobenzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2C=NC(=C2)C)C=CC(=C1)OC PKCHYFWKPIEVHP-UHFFFAOYSA-N 0.000 claims 1
- KKPJNQJIHIOJGD-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-2-(4-methylpyrazol-1-yl)-5-nitrobenzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=CC(=C2)C)C=CC(=C1)OC KKPJNQJIHIOJGD-UHFFFAOYSA-N 0.000 claims 1
- QMBXXPVJJILNEO-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-2-(5-methyl-1,3,4-oxadiazol-2-yl)-5-nitrobenzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])C=2OC(=NN=2)C)C=CC(=C1)OC QMBXXPVJJILNEO-UHFFFAOYSA-N 0.000 claims 1
- QJMGHOONDLZSCM-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-2-[4-(2-hydroxyethyl)pyrazol-1-yl]-5-nitrobenzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=CC(=C2)CCO)C=CC(=C1)OC QJMGHOONDLZSCM-UHFFFAOYSA-N 0.000 claims 1
- WVSATIGXTGFJJD-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-2-[4-(2-methoxyethyl)pyrazol-1-yl]-5-nitrobenzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=CC(=C2)CCOC)C=CC(=C1)OC WVSATIGXTGFJJD-UHFFFAOYSA-N 0.000 claims 1
- ONJAHTOJIPSTHG-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-2-fluoro-5-nitrobenzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])F)C=CC(=C1)OC ONJAHTOJIPSTHG-UHFFFAOYSA-N 0.000 claims 1
- LSJJJNMIUQAIMS-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-(4-propan-2-ylpyrazol-1-yl)benzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=CC(=C2)C(C)C)C=CC(=C1)OC LSJJJNMIUQAIMS-UHFFFAOYSA-N 0.000 claims 1
- AKAKMBCAYCYNJP-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-[3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl]benzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])C2=NC(=NO2)C(F)(F)F)C=CC(=C1)OC AKAKMBCAYCYNJP-UHFFFAOYSA-N 0.000 claims 1
- SFDBUFVDNSHSOF-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]benzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=C(N=C2)C(F)(F)F)C=CC(=C1)OC SFDBUFVDNSHSOF-UHFFFAOYSA-N 0.000 claims 1
- UQQPAPXQEBZVLJ-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-[4-(2,2,2-trifluoroethyl)pyrazol-1-yl]benzenesulfonamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(ccc2-n2cc(CC(F)(F)F)cn2)[N+]([O-])=O)c(OC)c1 UQQPAPXQEBZVLJ-UHFFFAOYSA-N 0.000 claims 1
- FCHGVOAFBNPOFH-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-[4-(2,2,2-trifluoroethylamino)pyrazol-1-yl]benzenesulfonamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(ccc2-n2cc(NCC(F)(F)F)cn2)[N+]([O-])=O)c(OC)c1 FCHGVOAFBNPOFH-UHFFFAOYSA-N 0.000 claims 1
- MNMLNTUJYASXFO-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-[4-(2-oxoethyl)pyrazol-1-yl]benzenesulfonamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(ccc2-n2cc(CC=O)cn2)[N+]([O-])=O)c(OC)c1 MNMLNTUJYASXFO-UHFFFAOYSA-N 0.000 claims 1
- ZLJNKPJOGNMHJB-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-[4-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=CC(=C2)C(F)(F)F)C=CC(=C1)OC ZLJNKPJOGNMHJB-UHFFFAOYSA-N 0.000 claims 1
- ZMFPILOIJLLGGW-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenesulfonamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(ccc2-c2noc(n2)C(F)(F)F)[N+]([O-])=O)c(OC)c1 ZMFPILOIJLLGGW-UHFFFAOYSA-N 0.000 claims 1
- IIWWGHMXIVJQDJ-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzenesulfonamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(ccc2-c2nnc(o2)C(F)(F)F)[N+]([O-])=O)c(OC)c1 IIWWGHMXIVJQDJ-UHFFFAOYSA-N 0.000 claims 1
- GAEWFDMNPFDKGU-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-pyrazolo[3,4-b]pyridin-2-ylbenzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=C3N=CC=CC3=C2)C=CC(=C1)OC GAEWFDMNPFDKGU-UHFFFAOYSA-N 0.000 claims 1
- QJYPEMSWMIBIDB-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-pyrazolo[3,4-c]pyridin-2-ylbenzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=C3C=NC=CC3=C2)C=CC(=C1)OC QJYPEMSWMIBIDB-UHFFFAOYSA-N 0.000 claims 1
- CDLGZSYJVYTYKJ-UHFFFAOYSA-N N-[(2,4-dimethoxyphenyl)methyl]-5-nitro-2-pyrazolo[4,3-b]pyridin-2-ylbenzenesulfonamide Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=C3C(N=CC=C3)=C2)C=CC(=C1)OC CDLGZSYJVYTYKJ-UHFFFAOYSA-N 0.000 claims 1
- PNASJKHRHZXHMA-UHFFFAOYSA-N N-[1-[4-[[2-(2-chlorophenyl)acetyl]amino]-2-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]pyrazol-4-yl]-2,2-difluoroacetamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)NC(C(F)F)=O)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O PNASJKHRHZXHMA-UHFFFAOYSA-N 0.000 claims 1
- WOLMYVDNYORCDL-UHFFFAOYSA-N N-[1-[4-[[2-(2-chlorophenyl)acetyl]amino]-2-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]pyrazol-4-yl]-3,3,3-trifluoro-2-methylpropanamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)NC(C(C(F)(F)F)C)=O)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O WOLMYVDNYORCDL-UHFFFAOYSA-N 0.000 claims 1
- ADYYDQABIFSIHW-UHFFFAOYSA-N N-[1-[4-[[2-(2-chlorophenyl)acetyl]amino]-2-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]pyrazol-4-yl]-3,3,3-trifluoropropanamide Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)NC(CC(F)(F)F)=O)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O ADYYDQABIFSIHW-UHFFFAOYSA-N 0.000 claims 1
- UBWGMAVRUHWNHG-UHFFFAOYSA-N N-[1-[4-[[2-(2-chlorophenyl)acetyl]amino]-2-sulfamoylphenyl]pyrazol-4-yl]-3,3,3-trifluoropropanamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2Cl)ccc1-n1cc(NC(=O)CC(F)(F)F)cn1 UBWGMAVRUHWNHG-UHFFFAOYSA-N 0.000 claims 1
- BNSIFAXJAQNLBK-UHFFFAOYSA-N N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-(4-methylpyrazol-1-yl)phenyl]-2-(2-fluorophenyl)acetamide Chemical compound COC1=C(CNS(=O)(=O)C=2C=C(C=CC=2N2N=CC(=C2)C)NC(CC2=C(C=CC=C2)F)=O)C=CC(=C1)OC BNSIFAXJAQNLBK-UHFFFAOYSA-N 0.000 claims 1
- YBHHIRSVZNIXME-UHFFFAOYSA-N N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-(4-propan-2-ylpyrazol-1-yl)phenyl]-2-(2-fluorophenyl)acetamide Chemical compound COC1=C(CNS(=O)(=O)C=2C=C(C=CC=2N2N=CC(=C2)C(C)C)NC(CC2=C(C=CC=C2)F)=O)C=CC(=C1)OC YBHHIRSVZNIXME-UHFFFAOYSA-N 0.000 claims 1
- FQOWKTRXLPVYRN-UHFFFAOYSA-N N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-[4-(2,2,2-trifluoroethyl)pyrazol-1-yl]phenyl]-2-(2-fluorophenyl)acetamide Chemical compound COc1ccc(CNS(=O)(=O)c2cc(NC(=O)Cc3ccccc3F)ccc2-n2cc(CC(F)(F)F)cn2)c(OC)c1 FQOWKTRXLPVYRN-UHFFFAOYSA-N 0.000 claims 1
- XFEUDQXBJGLTEB-UHFFFAOYSA-N N-[3-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]phenyl]-2-(2-fluorophenyl)acetamide Chemical compound COC1=C(CNS(=O)(=O)C=2C=C(C=CC=2C=2OC(=NN=2)C(F)(F)F)NC(CC2=C(C=CC=C2)F)=O)C=CC(=C1)OC XFEUDQXBJGLTEB-UHFFFAOYSA-N 0.000 claims 1
- TWBGNRGFIAOVDB-UHFFFAOYSA-N N-[3-sulfamoyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenyl]-2-[2-(trifluoromethoxy)phenyl]acetamide Chemical compound S(N)(=O)(=O)C=1C=C(C=CC=1N1N=CC(=C1)C(F)(F)F)NC(CC1=C(C=CC=C1)OC(F)(F)F)=O TWBGNRGFIAOVDB-UHFFFAOYSA-N 0.000 claims 1
- KPMIIVCYNIHLND-UHFFFAOYSA-N N-[3-sulfamoyl-4-[5-(trifluoromethyl)pyridin-3-yl]phenyl]-2-[2-(trifluoromethyl)phenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2C(F)(F)F)ccc1-c1cncc(c1)C(F)(F)F KPMIIVCYNIHLND-UHFFFAOYSA-N 0.000 claims 1
- WAAXXNKFTNZFPG-UHFFFAOYSA-N N-[4-(3-cyclopropylpyrazol-1-yl)-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]-2-(2-fluorophenyl)acetamide Chemical compound C1(CC1)C1=NN(C=C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O WAAXXNKFTNZFPG-UHFFFAOYSA-N 0.000 claims 1
- SNDWIHIUWCSOKL-UHFFFAOYSA-N N-[4-(4-aminopyrazol-1-yl)-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]-2-(2-chlorophenyl)acetamide Chemical compound NC=1C=NN(C=1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O SNDWIHIUWCSOKL-UHFFFAOYSA-N 0.000 claims 1
- VXKGFJKUDZCSBB-UHFFFAOYSA-N N-[4-(4-bromopyrazol-1-yl)-3-sulfamoylphenyl]-2-(2-chloro-4,5-difluorophenyl)acetamide N-[4-(4-bromopyrazol-1-yl)-3-sulfamoylphenyl]-2-[2-(trifluoromethoxy)phenyl]acetamide Chemical compound BrC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C(=C1)F)F)Cl)=O)S(N)(=O)=O.BrC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)OC(F)(F)F)=O)S(N)(=O)=O VXKGFJKUDZCSBB-UHFFFAOYSA-N 0.000 claims 1
- ZMNIJVKJSFULNS-UHFFFAOYSA-N N-[4-(4-bromopyrazol-1-yl)-3-sulfamoylphenyl]-2-(2-chloro-4-fluorophenyl)acetamide N-[4-(4-bromopyrazol-1-yl)-3-sulfamoylphenyl]-2-[2-(difluoromethoxy)phenyl]acetamide Chemical compound BrC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)OC(F)F)=O)S(N)(=O)=O.BrC=1C=NN(C1)C1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)F)Cl)=O)S(N)(=O)=O ZMNIJVKJSFULNS-UHFFFAOYSA-N 0.000 claims 1
- YAJRZXMMIOWVJF-UHFFFAOYSA-N N-[4-(4-chloropyrazol-1-yl)-3-sulfamoylphenyl]-2-(2-fluorophenyl)acetamide 2-[2-(difluoromethyl)phenyl]-N-[4-(4-fluoropyrazol-1-yl)-3-sulfamoylphenyl]acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2F)ccc1-n1cc(Cl)cn1.NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2C(F)F)ccc1-n1cc(F)cn1 YAJRZXMMIOWVJF-UHFFFAOYSA-N 0.000 claims 1
- ZISOJQFFXYSNHT-UHFFFAOYSA-N N-[4-(4-cyclopropylimidazol-1-yl)-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]-2-(2-fluorophenyl)acetamide Chemical compound FC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1C=NC(=C1)C1CC1)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O ZISOJQFFXYSNHT-UHFFFAOYSA-N 0.000 claims 1
- ZDKXYEOQXZXQOG-UHFFFAOYSA-N N-[4-(6-chloropyridin-3-yl)-3-sulfamoylphenyl]-2-(3-fluorophenyl)acetamide N-[4-(6-chloropyridin-3-yl)-3-sulfamoylphenyl]-2-[2-(trifluoromethyl)phenyl]acetamide Chemical compound ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=CC(=CC=C1)F)=O)S(N)(=O)=O.ClC1=CC=C(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)C(F)(F)F)=O)S(N)(=O)=O ZDKXYEOQXZXQOG-UHFFFAOYSA-N 0.000 claims 1
- VSRNOFJJZPTFIL-UHFFFAOYSA-N N-[4-[3-(difluoromethyl)-1,2,4-triazol-1-yl]-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]-2-(2-fluorophenyl)acetamide Chemical compound FC(C1=NN(C=N1)C1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)F)=O)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O)F VSRNOFJJZPTFIL-UHFFFAOYSA-N 0.000 claims 1
- GZJDMISPWHIFDF-UHFFFAOYSA-N N-[4-[4-(2,2-difluoroethylamino)pyrazol-1-yl]-3-sulfamoylphenyl]-2-(2-fluorophenyl)acetamide Chemical compound NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2F)ccc1-n1cc(NCC(F)F)cn1 GZJDMISPWHIFDF-UHFFFAOYSA-N 0.000 claims 1
- MHBQOIULJHHTHJ-UHFFFAOYSA-N N-[4-bromo-3-(dimethylaminomethylideneamino)sulfonylphenyl]-2-(2-chloro-4-fluorophenyl)acetamide Chemical compound BrC1=C(C=C(C=C1)NC(CC1=C(C=C(C=C1)F)Cl)=O)S(N=CN(C)C)(=O)=O MHBQOIULJHHTHJ-UHFFFAOYSA-N 0.000 claims 1
- CLQUVIBPKDMBSS-UHFFFAOYSA-N N-[4-bromo-3-[(2,4-dimethoxyphenyl)methylsulfamoyl]phenyl]-2-(2-chlorophenyl)acetamide Chemical compound BrC1=C(C=C(C=C1)NC(CC1=C(C=CC=C1)Cl)=O)S(NCC1=C(C=C(C=C1)OC)OC)(=O)=O CLQUVIBPKDMBSS-UHFFFAOYSA-N 0.000 claims 1
- QVOZYNYJXUKTKB-UHFFFAOYSA-N N-[6-(4-cyanopyrazol-1-yl)-5-sulfamoylpyridin-3-yl]-2-(2-fluorophenyl)acetamide 2-(2-fluorophenyl)-N-[5-sulfamoyl-6-[4-(trifluoromethyl)pyrazol-1-yl]pyridin-3-yl]acetamide Chemical compound C(#N)C=1C=NN(C1)C1=C(C=C(C=N1)NC(CC1=C(C=CC=C1)F)=O)S(N)(=O)=O.FC1=C(C=CC=C1)CC(=O)NC=1C=NC(=C(C1)S(N)(=O)=O)N1N=CC(=C1)C(F)(F)F QVOZYNYJXUKTKB-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000028389 Nerve injury Diseases 0.000 claims 1
- 208000005890 Neuroma Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000004983 Phantom Limb Diseases 0.000 claims 1
- 206010056238 Phantom pain Diseases 0.000 claims 1
- 206010065347 Premenstrual pain Diseases 0.000 claims 1
- 206010036968 Prostatic pain Diseases 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 206010038419 Renal colic Diseases 0.000 claims 1
- BXQRKQHWHNFPOJ-UHFFFAOYSA-N S(N)(=O)(=O)C=1C=C(C=CC1C=1C=NC=C(C1)C(F)(F)F)NC(CC1=CC=C(C=C1)C(F)(F)F)=O.ClC1=C(C(=CC=C1)F)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O Chemical compound S(N)(=O)(=O)C=1C=C(C=CC1C=1C=NC=C(C1)C(F)(F)F)NC(CC1=CC=C(C=C1)C(F)(F)F)=O.ClC1=C(C(=CC=C1)F)CC(=O)NC1=CC(=C(C=C1)C=1C=NC=C(C1)C(F)(F)F)S(N)(=O)=O BXQRKQHWHNFPOJ-UHFFFAOYSA-N 0.000 claims 1
- 208000010261 Small Fiber Neuropathy Diseases 0.000 claims 1
- 206010073928 Small fibre neuropathy Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 208000018912 cluster headache syndrome Diseases 0.000 claims 1
- 201000003146 cystitis Diseases 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- VRGIWLCGOHWGOG-UHFFFAOYSA-N ethyl 1-[2-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-nitrophenyl]pyrazole-4-carboxylate Chemical compound COC1=C(CNS(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])N2N=CC(=C2)C(=O)OCC)C=CC(=C1)OC VRGIWLCGOHWGOG-UHFFFAOYSA-N 0.000 claims 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims 1
- 230000001771 impaired effect Effects 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- GYEQQAXPQGXACL-UHFFFAOYSA-N methyl 1-[4-[[2-(2-chlorophenyl)acetyl]amino]-2-sulfamoylphenyl]pyrazole-4-carboxylate Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)N1N=CC(=C1)C(=O)OC)S(N)(=O)=O GYEQQAXPQGXACL-UHFFFAOYSA-N 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 230000008764 nerve damage Effects 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 208000017692 primary erythermalgia Diseases 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 201000007094 prostatitis Diseases 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 201000002793 renal fibrosis Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- MZOOWDNOTXAKNO-UHFFFAOYSA-N tert-butyl 3-[4-[[2-(2-chlorophenyl)acetyl]amino]-2-(dimethylaminomethylideneamino)sulfonylphenyl]pyrrole-1-carboxylate Chemical compound ClC1=C(C=CC=C1)CC(=O)NC1=CC(=C(C=C1)C1=CN(C=C1)C(=O)OC(C)(C)C)S(N=CN(C)C)(=O)=O MZOOWDNOTXAKNO-UHFFFAOYSA-N 0.000 claims 1
- KHDVFYNSADNNQF-UHFFFAOYSA-N tert-butyl 4-[4-(4-amino-2-sulfamoylphenyl)pyrazol-1-yl]piperidine-1-carboxylate Chemical compound NC1=CC(=C(C=C1)C=1C=NN(C=1)C1CCN(CC1)C(=O)OC(C)(C)C)S(N)(=O)=O KHDVFYNSADNNQF-UHFFFAOYSA-N 0.000 claims 1
- UYYPSSYSBJUEGZ-UHFFFAOYSA-N tert-butyl N-(2,2-difluoroethyl)-N-[[1-[2-[(2,4-dimethoxyphenyl)methylsulfamoyl]-4-nitrophenyl]pyrazol-4-yl]methyl]carbamate Chemical compound COc1ccc(CNS(=O)(=O)c2cc(ccc2-n2cc(CN(CC(F)F)C(=O)OC(C)(C)C)cn2)[N+]([O-])=O)c(OC)c1 UYYPSSYSBJUEGZ-UHFFFAOYSA-N 0.000 claims 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 230000000472 traumatic effect Effects 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 206010044652 trigeminal neuralgia Diseases 0.000 claims 1
- 208000000143 urethritis Diseases 0.000 claims 1
- 210000004291 uterus Anatomy 0.000 claims 1
- 208000009935 visceral pain Diseases 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021198484A JP7104232B2 (ja) | 2016-05-03 | 2021-12-07 | 芳香族スルホンアミド誘導体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16167996.4 | 2016-05-03 | ||
| EP16167996 | 2016-05-03 | ||
| PCT/EP2017/059882 WO2017191000A1 (en) | 2016-05-03 | 2017-04-26 | Aromatic sulfonamide derivatives |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021198484A Division JP7104232B2 (ja) | 2016-05-03 | 2021-12-07 | 芳香族スルホンアミド誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019519484A JP2019519484A (ja) | 2019-07-11 |
| JP2019519484A5 true JP2019519484A5 (enExample) | 2020-06-11 |
| JP7033079B2 JP7033079B2 (ja) | 2022-03-09 |
Family
ID=55910814
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018557818A Active JP7033079B2 (ja) | 2016-05-03 | 2017-04-26 | 芳香族スルホンアミド誘導体 |
| JP2021198484A Active JP7104232B2 (ja) | 2016-05-03 | 2021-12-07 | 芳香族スルホンアミド誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021198484A Active JP7104232B2 (ja) | 2016-05-03 | 2021-12-07 | 芳香族スルホンアミド誘導体 |
Country Status (42)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10844016B2 (en) * | 2016-05-03 | 2020-11-24 | Bayer Pharma Aktiengesellschaft | Aromatic sulfonamide derivatives |
| EP3529246B1 (en) * | 2016-10-24 | 2023-10-18 | FMC Corporation | Oxadiazoles having fungicidal activity |
| WO2018104307A1 (en) * | 2016-12-09 | 2018-06-14 | Bayer Pharma Aktiengesellschaft | Aromatic sulfonamide derivatives and their use as anatagon i sts or negative allosteric modulators of p2x4 |
| WO2018210729A1 (en) * | 2017-05-18 | 2018-11-22 | Bayer Pharma Aktiengesellschaft | Aromatic sulfonamide derivatives as antagonists or negative allosteric modulators of p2x4 receptor |
| JOP20190278A1 (ar) * | 2017-05-31 | 2019-11-28 | Novartis Ag | مركبات 5، 6-ثنائية الحلقة مندمجة وتركيبات لعلاج الأمراض الطفيلية |
| EP3700891A1 (en) * | 2017-10-29 | 2020-09-02 | Bayer Aktiengesellschaft | Aromatic sulfonamide derivatives for the treatment of ischemic stroke |
| IL279810B2 (en) | 2018-08-31 | 2025-03-01 | Xenon Pharmaceuticals Inc | Heteroaryl-modified sulfonamide compounds and their use as medicinal agents |
| CA3159689C (en) * | 2019-11-29 | 2025-05-27 | Wuhan Ll Science And Technology Development Co., Ltd. | COMPOUND CONTAINING AN ORTHOCODENSE HETEROCYCLE AND USE AS A P2X4 ANTAGONIST |
| CN113082023B (zh) * | 2019-12-23 | 2024-03-01 | 武汉朗来科技发展有限公司 | P2x3抑制剂和p2x4抑制剂的药物组合及其应用 |
| CA3163440A1 (en) * | 2019-12-30 | 2021-07-08 | Jun LOU | Fused ring compound and application thereof |
| WO2022002860A1 (en) | 2020-06-30 | 2022-01-06 | Bayer Aktiengesellschaft | Use of n-phenylacetamides having p2x4 receptor antagonistic activity for treating certain ocular disorders |
| AU2021302525A1 (en) | 2020-06-30 | 2022-11-17 | Bayer Aktiengesellschaft | Substituted N-phenylacetamides having P2X4 receptor antagonistic activity |
| CN111743864B (zh) * | 2020-08-05 | 2022-04-01 | 牡丹江医学院 | 一种体育外伤喷雾剂及其制备方法 |
| WO2022049253A1 (en) | 2020-09-07 | 2022-03-10 | Bayer Aktiengesellschaft | Substituted n-heteroaryl-n-pyridinylacetamides as p2x4 modulators |
| TW202239748A (zh) * | 2021-01-27 | 2022-10-16 | 大陸商武漢朗來科技發展有限公司 | 芳香化合物、其製備方法及應用 |
| JP7644217B2 (ja) | 2021-03-01 | 2025-03-11 | 日本農薬株式会社 | スルホンアミド基を有する縮合複素環化合物又はその塩類及び該化合物若しくはその塩類を含有する農園芸用殺虫剤又は動物用の外部若しくは内部寄生虫防除剤並びにそれらの使用方法 |
| WO2022221181A1 (en) * | 2021-04-12 | 2022-10-20 | Yale University | Compositions and methods for the treatment and prevention of cancer |
| US11975290B2 (en) | 2022-03-17 | 2024-05-07 | International Business Machines Corporation | Cyclopropeneimines for capture and transfer of carbon dioxide |
| US11878269B2 (en) | 2022-03-17 | 2024-01-23 | International Business Machines Corporation | Cyclopropeneimines for capture and transfer of carbon dioxide |
| CA3246964A1 (en) * | 2022-03-31 | 2025-07-09 | Nippon Chemiphar Co., Ltd. | PHARMACEUTICAL COMPOSITION FOR PREVENTING, SUPPRESSING OR TREATMENT OF A SYMPTOM ASSOCIATED WITH A PSEUDOALLEGIC REACTION |
| US12415889B2 (en) | 2022-08-19 | 2025-09-16 | International Business Machines Corporation | Cyclopropenimines for activation of carbon dioxide |
| US12479793B2 (en) | 2022-08-19 | 2025-11-25 | International Business Machines Corporation | Cyclopropenimines for mineralization of carbon dioxide |
| US12478951B2 (en) | 2022-08-19 | 2025-11-25 | International Business Machines Corporation | Cyclopropenimines for activation of carbon dioxide |
| WO2024255861A1 (zh) | 2023-06-16 | 2024-12-19 | 武汉朗来科技发展有限公司 | 一种p2x4抑制剂固体分散体及其制备方法和应用 |
| WO2025051851A1 (en) | 2023-09-05 | 2025-03-13 | Bayer Aktiengesellschaft | Pharmaceutical dosage forms comprising 2-(2-chlorophenyl)-n-[4-(4-cyano-1h-pyrazol-1-yl)-3-sulfamoylphenyl]acetamide |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| US5770615A (en) * | 1996-04-04 | 1998-06-23 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| US5994398A (en) * | 1996-12-11 | 1999-11-30 | Elan Pharmaceuticals, Inc. | Arylsulfonamides as phospholipase A2 inhibitors |
| ES2900504T3 (es) | 2009-09-03 | 2022-03-17 | Bristol Myers Squibb Co | Quinazolinas como inhibidores de los canales iónicos de potasio |
| JP2013523658A (ja) | 2010-03-26 | 2013-06-17 | グラクソ グループ リミテッド | キナーゼ阻害剤としてのピラゾリル‐ピリミジン |
| EP3450432A1 (en) | 2010-05-17 | 2019-03-06 | Incozen Therapeutics Pvt. Ltd. | Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued - 3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases |
| CA2807354C (en) | 2010-07-13 | 2018-06-05 | Nippon Chemiphar Co., Ltd. | P2x4 receptor antagonist |
| EP2803662B1 (en) | 2012-01-13 | 2017-03-01 | Nippon Chemiphar Co., Ltd. | P2x4 receptor antagonist |
| WO2014202779A1 (en) * | 2013-06-21 | 2014-12-24 | L'oreal | Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition |
| US9873683B2 (en) | 2013-07-12 | 2018-01-23 | Nippon Chemiphar Co., Ltd | P2X4 receptor antagonist |
| CA2921200C (en) * | 2013-07-12 | 2021-07-13 | Nippon Chemiphar Co., Ltd. | Diazepinyl derivatives and compositions therof useful as p2x4 receptor antagonist |
| WO2015088564A1 (en) | 2013-12-13 | 2015-06-18 | Sunovion Pharmaceuticals Inc. | P2x4 receptor modulating compounds |
| WO2015088565A1 (en) | 2013-12-13 | 2015-06-18 | Sunovion Pharmaceuticals Inc. | P2x4 receptor modulating compounds and methods of use thereof |
| US20180338980A1 (en) * | 2015-06-10 | 2018-11-29 | Bayer Pharma Aktiengesellschaft | Aromatic sulfonamide derivatives |
| CN109414454A (zh) | 2016-05-03 | 2019-03-01 | 加莱拉实验室有限责任公司 | 用于癌症治疗的组合疗法 |
| US9988367B2 (en) | 2016-05-03 | 2018-06-05 | Bayer Pharma Aktiengesellschaft | Amide-substituted pyridinyltriazole derivatives and uses thereof |
| US10844016B2 (en) * | 2016-05-03 | 2020-11-24 | Bayer Pharma Aktiengesellschaft | Aromatic sulfonamide derivatives |
| WO2018104307A1 (en) * | 2016-12-09 | 2018-06-14 | Bayer Pharma Aktiengesellschaft | Aromatic sulfonamide derivatives and their use as anatagon i sts or negative allosteric modulators of p2x4 |
| WO2018104305A1 (en) * | 2016-12-09 | 2018-06-14 | Bayer Pharma Aktiengesellschaft | Field of application of the invention |
| WO2018210729A1 (en) * | 2017-05-18 | 2018-11-22 | Bayer Pharma Aktiengesellschaft | Aromatic sulfonamide derivatives as antagonists or negative allosteric modulators of p2x4 receptor |
| EP3700891A1 (en) * | 2017-10-29 | 2020-09-02 | Bayer Aktiengesellschaft | Aromatic sulfonamide derivatives for the treatment of ischemic stroke |
-
2017
- 2017-04-26 US US16/098,767 patent/US10844016B2/en active Active
- 2017-04-26 TN TNP/2018/000369A patent/TN2018000369A1/fr unknown
- 2017-04-26 MX MX2018013490A patent/MX382068B/es unknown
- 2017-04-26 CN CN201780041379.2A patent/CN109415321B/zh active Active
- 2017-04-26 MA MA45020A patent/MA45020B1/fr unknown
- 2017-04-26 HR HRP20201746TT patent/HRP20201746T1/hr unknown
- 2017-04-26 ES ES17724498T patent/ES2829270T3/es active Active
- 2017-04-26 SG SG11201809126RA patent/SG11201809126RA/en unknown
- 2017-04-26 RS RS20201318A patent/RS61012B1/sr unknown
- 2017-04-26 GE GEAP202114943A patent/GEAP202114943A/en unknown
- 2017-04-26 AU AU2017260125A patent/AU2017260125B2/en active Active
- 2017-04-26 HU HUE17724498A patent/HUE051348T2/hu unknown
- 2017-04-26 KR KR1020187034452A patent/KR102388962B1/ko active Active
- 2017-04-26 EA EA201892450A patent/EA201892450A1/ru unknown
- 2017-04-26 CR CR20180528A patent/CR20180528A/es unknown
- 2017-04-26 CN CN202210645365.4A patent/CN114984003B/zh active Active
- 2017-04-26 EP EP17724498.5A patent/EP3458443B1/en active Active
- 2017-04-26 LT LTEP17724498.5T patent/LT3458443T/lt unknown
- 2017-04-26 JP JP2018557818A patent/JP7033079B2/ja active Active
- 2017-04-26 CU CU2018000137A patent/CU24516B1/es unknown
- 2017-04-26 WO PCT/EP2017/059882 patent/WO2017191000A1/en not_active Ceased
- 2017-04-26 UA UAA201811683A patent/UA122819C2/uk unknown
- 2017-04-26 GE GEAP201714943A patent/GEP20217316B/en unknown
- 2017-04-26 DK DK17724498.5T patent/DK3458443T3/da active
- 2017-04-26 PT PT177244985T patent/PT3458443T/pt unknown
- 2017-04-26 PL PL17724498T patent/PL3458443T3/pl unknown
- 2017-04-26 CN CN202210644997.9A patent/CN115054600B/zh active Active
- 2017-04-26 EP EP20191219.3A patent/EP3763704A1/en active Pending
- 2017-04-26 PE PE2018002313A patent/PE20190913A1/es unknown
- 2017-04-26 MY MYPI2018704032A patent/MY187845A/en unknown
- 2017-04-26 SI SI201730430T patent/SI3458443T1/sl unknown
- 2017-05-02 TW TW106114429A patent/TWI723158B/zh not_active IP Right Cessation
- 2017-05-03 AR ARP170101138A patent/AR108356A1/es not_active Application Discontinuation
- 2017-05-03 JO JOJO/P/2017/0107A patent/JOP20170107B1/ar active
- 2017-05-03 UY UY0001037224A patent/UY37224A/es active IP Right Grant
-
2018
- 2018-10-24 IL IL262580A patent/IL262580B/en unknown
- 2018-10-30 PH PH12018502307A patent/PH12018502307A1/en unknown
- 2018-11-01 NI NI201800116A patent/NI201800116A/es unknown
- 2018-11-02 DO DO2018000241A patent/DOP2018000241A/es unknown
- 2018-11-02 CO CONC2018/0011935A patent/CO2018011935A2/es unknown
- 2018-11-04 SA SA518400371A patent/SA518400371B1/ar unknown
- 2018-11-05 CL CL2018003135A patent/CL2018003135A1/es unknown
- 2018-11-05 SV SV2018005778A patent/SV2018005778A/es unknown
- 2018-11-06 EC ECSENADI201882774A patent/ECSP18082774A/es unknown
- 2018-11-30 ZA ZA2018/08130A patent/ZA201808130B/en unknown
-
2020
- 2020-10-09 US US17/067,434 patent/US11524938B2/en active Active
- 2020-11-16 CY CY20201101080T patent/CY1123801T1/el unknown
-
2021
- 2021-12-07 JP JP2021198484A patent/JP7104232B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20201746T1 (hr) | Aromatski derivati sulfonamida | |
| JP2019504821A5 (enExample) | ||
| JP2016523911A5 (enExample) | ||
| RU2017124425A (ru) | Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg | |
| JP2017500364A5 (enExample) | ||
| US20090253676A1 (en) | Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes | |
| JP2014527959A5 (enExample) | ||
| JP2014525444A5 (enExample) | ||
| HRP20160539T1 (hr) | Antagonisti trpv4 | |
| JP2018524331A5 (enExample) | ||
| HRP20191140T1 (hr) | Spojevi i pripravci kao inhibitori c-kit kinaze | |
| ME02856B (me) | Aminopirimidinilni spojevi kao inhibitori jak | |
| JP2011518836A5 (enExample) | ||
| JP2015522002A5 (enExample) | ||
| IL306126A (en) | Heterocyclic compounds | |
| JP2016510035A5 (enExample) | ||
| JP2014525448A5 (enExample) | ||
| RU2016141646A (ru) | Ингибиторы trka киназы, основанные на них композиции и способы | |
| JP2017512794A5 (enExample) | ||
| RU2012146246A (ru) | Антибактериальные производные изохинолин-3-илмочевины | |
| HRP20200440T1 (hr) | 1h-pirazolo[4,3-b]piridini kao pde1 inhibitori | |
| WO2011119518A1 (en) | Soluble guanylate cyclase activators | |
| JP2016518344A5 (enExample) | ||
| JP2022505707A5 (enExample) | ||
| RU2015144386A (ru) | Циклоалкилнитрилпиразолопиридоны в качестве ингибиторов янус-киназы |